Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph.
You can order HTA monographs from our Despatch Agents:
-fax (with credit card or official purchase order) -post (with credit card or official purchase order or cheque) -phone during office hours (credit card only).
Additionally the HTA website allows you either to pay securely by credit card or to print out your order and then post or fax it. NHS libraries can subscribe free of charge. Public libraries can subscribe at a very reduced cost of £100 for each volume (normally comprising 30-40 titles). The commercial subscription rate is £300 per volume. Please see our website for details. Subscriptions can only be purchased for the current or forthcoming volume.
Contact details are as follows:

Payment methods
Paying by cheque
If you pay by cheque, the cheque must be in pounds sterling, made payable to Direct Mail Works Ltd and drawn on a bank with a UK address.
Paying by credit card
The following cards are accepted by phone, fax, post or via the website ordering pages: Delta, Eurocard, Mastercard, Solo, Switch and Visa. We advise against sending credit card details in a plain email.
Paying by official purchase order
You can post or fax these, but they must be from public bodies (i.e. NHS or universities) within the UK. We cannot at present accept purchase orders from commercial companies or from outside the UK.
How do I get a copy of HTA on CD?
Please use the form on the HTA website (www.hta.ac.uk/htacd.htm). Or contact Direct Mail Works (see contact details above) by email, post, fax or phone. HTA on CD is currently free of charge worldwide.
The website also provides information about the HTA Programme and lists the membership of the various committees.
HTA Background
Physical activity is known to be beneficial in reducing the risk of cardiovascular disease, but there is a high prevalence of inactivity in the UK population. Primary care is an important setting for encouraging increased physical activity, but brief advice from GPs may not be effective in increasing physical activity levels. Exercise referral schemes, also known as exercise on prescription, have been developed to address this issue and are increasingly popular, but have not been rigorously evaluated.
Objectives
Building on a large local exercise referral scheme, the objectives were to evaluate and compare the effectiveness and cost-effectiveness of a leisure centre-based exercise programme, an instructorled walking programme and advice only in patients referred for exercise by their GPs.
Methods
Design
The study was a single-centre, parallel-group, randomised controlled trial, consisting of three arms, with the primary comparison at 6 months. The two structured exercise groups were followed for a further 6 months. Subjects in the control arm were rerandomised to one of the other trial arms and followed for a further year, although these data are not included in this report.
Setting
Assessments were carried out at Copthall Leisure Centre in Barnet, an outer London borough, and exercise programmes conducted there and at three other leisure centres and a variety of locations suitable for supervised walking throughout the borough.
Participants
Participants were aged between 40 and 74 years, not currently physically active and with at least one of the following cardiovascular risk factors:
raised cholesterol, controlled moderate to mild hypertension, obesity, current smoking, diabetes and/or a family history of myocardial infarction at an early age.
Interventions
Of 1105 referrals received at the leisure centre over a 3-year period, 943 patients agreed to participate in the trial. They were assessed in cohorts and randomised to one of the following three arms: a 10-week programme of supervised exercise classes, two to three times a week in a local leisure centre; a 10-week instructor-led walking programme, two to three times a week; an advice-only control group who received tailored advice and information on physical activity including information on local exercise facilities. After 6 months the control group were rerandomised to one of the other trial arms. Assessments took place before randomisation, at 10 weeks (in a random 50% subsample of participants), 6 months and 1 year in the leisure centre and walking arms. The control participants were similarly assessed up to 6 months and then reassessed at the same intervals as those initially randomised to the leisure centre and walking groups.
Main outcome measures
The primary outcome measures were changes in self-reported exercise behaviour, blood pressure, total cholesterol and lipid subfractions. Secondary outcomes included changes in anthropometry (waist-hip ratio, body mass index and percentage body fat), cardiorespiratory fitness, flexibility, strength and power, self-reported lifestyle behaviour, general and psychological health status, quality of life and health service usage.
The costs of providing and making use of the service were quantified for economic evaluation.
Results
Follow-up rates were 66% of those eligible at the 10-week assessment, 60% at 6 months and 50% at 1 year. Primary outcomes were analysed by intention to treat.
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Executive summary ᭤ All three study groups increased their duration of activity of at least moderate intensity by 10 weeks. By 6 months, the increase was somewhat attenuated, but the duration of at least moderate activity remained significantly higher than at baseline, the greatest change occurring in the walking group. At 1 year, both leisure centre and walking groups maintained significant increases compared with baseline. However, there was no significant difference between the increases in duration of at least moderate activity in the three study groups at any assessment point.
There was a net increase in the proportion of participants achieving at least 150 minutes per week of at least moderate activity in the sport/leisure and walking categories in all three study groups: at 6 months, the net increases were 13.8% in the leisure centre group, 11.1% in the walking group and 7.5% in the advice-only group.
There were significant reductions in systolic and diastolic blood pressure in all groups at each assessment point compared with baseline, the largest reductions of about 6/4.5 mmHg being observed at 1 year in the leisure centre and walking groups. There were also significant and sustained improvements in cardiorespiratory fitness and leg extensor power, and small reductions in total and low-density lipoprotein cholesterol in all groups, but there were no consistent differences between the groups for any parameter over time.
All three groups showed improvement in Hospital Anxiety and Depression Scale anxiety and Short Form 36 (SF-36) mental well-being scores 6 months after the beginning of the trial. Leisure centre and walking groups maintained this improvement at 1 year. There were no differences between groups.
Costs to the participants amounted to £100 for the leisure centre scheme and £84 for the walking scheme, while provider costs were £186 and £92, respectively. Changes in overall SF-36 scores were small and advice only appeared the most costeffective intervention.
Conclusions Implications for healthcare
The results of this trial suggest that referral for tailored advice, supported by written materials, including details of locally available facilities, supplemented by detailed assessments may be effective in increasing physical activity. The inclusion of a 10-week programme of supervised exercise classes or walks as a formal component of the scheme may not be more effective than the provision of information about their availability. On cost-effectiveness grounds, assessment and advice alone from an exercise specialist may be appropriate to initiate action in the first instance. Subsidised schemes may be best concentrated on patients at higher absolute risk, or with specific conditions for which particular programmes may be beneficial. Walking appears to be as effective as leisure centre classes and is cheaper. Efforts should be directed towards maintenance of increased activity, with proven measures such as telephone support.
Recommendations for research
An updated meta-analysis of published exercise interventions should be undertaken using the standardised mean difference approach.
To improve future comparability of exercise intervention trials, standardised methods should be developed for measuring and presenting outcomes. This should include the development of guidelines both on the content and method of application of a standard physical activity questionnaire for trial use and on the way in which changes in duration and intensity of physical activity and in energy expenditure are best presented.
Research should identify how physical activity questionnaires might best be supplemented by objective measurements, including measures of cardiorespiratory fitness in field trials and whether simple submaximal fitness tests can be usefully incorporated into routine practice.
Research should aim to identify the components of interventions that may be beneficial for particular target groups in comparison with minimal intervention. These should include the frequency and intensity of support required to maximise exercise continuation, the value of physical assessment procedures and feedback as a stimulus to continue exercise, and the place of professional compared with lay advisers.
The effectiveness and cost-effectiveness of opportunistic referral by GPs and practice nurses versus proactive cold-calling of at-risk individuals on practice lists should be compared.
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Alternative strategies for involving groups underrepresented in present schemes, including men and members of deprived communities and specific minority groups, should be compared.
Studies of schemes should include qualitative research with referring clinicians and participants to determine the reasons for success or failure and should allow for long-term follow-up. 
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T he Health Technology Assessment (HTA) programme, now part of the National Institute for Health Research (NIHR), was set up in 1993. It produces high-quality research information on the costs, effectiveness and broader impact of health technologies for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined to include all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care, rather than settings of care. The research findings from the HTA Programme directly influence decision-making bodies such as the National Institute for Health and Clinical Excellence (NICE) and the National Screening Committee (NSC). HTA findings also help to improve the quality of clinical practice in the NHS indirectly in that they form a key component of the 'National Knowledge Service'. The HTA Programme is needs-led in that it fills gaps in the evidence needed by the NHS. There are three routes to the start of projects. First is the commissioned route. Suggestions for research are actively sought from people working in the NHS, the public and consumer groups and professional bodies such as royal colleges and NHS trusts. These suggestions are carefully prioritised by panels of independent experts (including NHS service users). The HTA Programme then commissions the research by competitive tender. Secondly, the HTA Programme provides grants for clinical trials for researchers who identify research questions. These are assessed for importance to patients and the NHS, and scientific rigour. Thirdly, through its Technology Assessment Report (TAR) call-off contract, the HTA Programme commissions bespoke reports, principally for NICE, but also for other policy-makers. TARs bring together evidence on the value of specific technologies. Some HTA research projects, including TARs, may take only months, others need several years. They can cost from as little as £40,000 to over £1 million, and may involve synthesising existing evidence, undertaking a trial, or other research collecting new data to answer a research problem. The final reports from HTA projects are peer-reviewed by a number of independent expert referees before publication in the widely read monograph series Health Technology Assessment.
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Reports are published in the HTA monograph series if (1) they have resulted from work for the HTA Programme, and (2) they are of a sufficiently high scientific quality as assessed by the referees and editors. Reviews in Health Technology Assessment are termed 'systematic' when the account of the search, appraisal and synthesis methods (to minimise biases and random errors) would, in theory, permit the replication of the review by others.
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